KAS
GMAB icon

Kestra Advisory Services’s Genmab GMAB Stock Holding History

Kestra Advisory Services’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Buy
12,016
+2,028
+20% +$53.9K ﹤0.01% 2671
2026
Q1 		$268K Buy
9,988
+6,855
+219% +$205K ﹤0.01% 2723
2025
Q4 		$96.5K Buy
+3,133
New +$97.7K ﹤0.01% 3457
2025
Q2 		– Sell
-2,567
Closed -$50.3K – 2890
2025
Q1 		$50.3K Buy
+2,567
New +$53.8K ﹤0.01% 2647
2024
Q3 		– Sell
-8,189
Closed -$206K – 2631
2024
Q2 		$206K Buy
+8,189
New +$232K ﹤0.01% 2391
2023
Q1 		– Sell
-11,842
Closed -$502K – 2169
2022
Q4 		$502K Buy
11,842
+795
+7% +$32.8K ﹤0.01% 1410
2022
Q3 		$355K Buy
11,047
+1,152
+12% +$40.5K ﹤0.01% 1509
2022
Q2 		$321K Buy
9,895
+661
+7% +$21.4K ﹤0.01% 1576
2022
Q1 		$334K Buy
9,234
+195
+2% +$6.69K ﹤0.01% 1532
2021
Q4 		$358K Sell
9,039
-1,770
-16% -$73.8K ﹤0.01% 1505
2021
Q3 		$472K Buy
10,809
+1,484
+16% +$66.6K ﹤0.01% 1413
2021
Q2 		$381K Buy
9,325
+1,394
+18% +$53.8K ﹤0.01% 1424
2021
Q1 		$260K Buy
+7,931
New +$298K ﹤0.01% 1552

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Kestra Advisory Services's GMAB Position: Q2 2026 in Review

Kestra Advisory Services increased its Genmab (GMAB) stake by 20% in Q2 2026, buying an estimated $53.9K and bringing the position to 12,016 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

Kestra Advisory Services first reported a position in GMAB in Q1 2021 and has held it in 13 quarters since. The position peaked at $502K in Q4 2022. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Kestra Advisory Services held 12,016 shares of Genmab worth $330K as of Q2 2026.
  • Kestra Advisory Services bought 2,028 Genmab shares in Q2 2026, an estimated $53.9K.
  • Genmab made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2671 holding.
  • Kestra Advisory Services first reported a position in Genmab in Q1 2021 and has held it in 13 quarters since.
  • Kestra Advisory Services's Genmab position peaked at $502K in Q4 2022.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.